This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baltatu, O. Articles by Bader, M. Search for Related Content PubMed PubMed Citation Articles by Baltatu, O. Articles by Bader, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2000;35:409.)
© 2000 American Heart Association, Inc.

Scientific Contributions

The Brain Renin-Angiotensin System Modulates Angiotensin II–Induced Hypertension and Cardiac Hypertrophy

Ovidiu Baltatu; José Antonio Silva, Jr; Detlev Ganten; Michael Bader

From the Max-Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.

Correspondence to Ovidiu Baltatu, MD, PhD, Max-Delbrück Center for Molecular Medicine, Robert-Rössle Str 10, Berlin-Buch D-13092, Germany. E-mail baltatu{at}mdc-berlin.de

Abstract—The potential involvement of the brain renin-angiotensin system in the hypertension induced by subpressor doses of angiotensin II was tested by the use of newly developed transgenic rats with permanent inhibition of brain angiotensinogen synthesis [TGR(ASrAOGEN)]. Basal systolic blood pressure monitored by telemetry was significantly lower in TGR(ASrAOGEN) than in Sprague-Dawley rats (parent strain) (122.5±1.5 versus 128.9±1.9 mm Hg, respectively; P<0.05). The increase in systolic blood pressure induced by 7 days of chronic angiotensin II infusion was significantly attenuated in TGR(ASrAOGEN) in comparison with control rats (29.8±4.2 versus 46.3±2.5 mm Hg, respectively; P<0.005). Moreover, an increase in heart/body weight ratio was evident only in Sprague-Dawley (11.1%) but not in TGR(ASrAOGEN) rats (2.8%). In contrast, mRNA levels of atrial natriuretic peptide (ANP) and collagen III in the left ventricle measured by ribonuclease protection assay were similarly increased in both TGR(ASrAOGEN) (ANP, x2.5; collagen III, x1.8) and Sprague-Dawley rats (ANP, x2.4; collagen III, x2) as a consequence of angiotensin II infusion. Thus, the expression of these genes in the left ventricle seems to be directly stimulated by angiotensin II. However, the hypertensive and hypertrophic effects of subpressor angiotensin II are at least in part mediated by the brain renin-angiotensin system.

Key Words: renin-angiotensin system • collagen • angiotensin II • hypertrophy • atrial natriuretic peptide

This article has been cited by other articles:

				H. Kobori, A. B. Alper Jr, R. Shenava, A. Katsurada, T. Saito, N. Ohashi, M. Urushihara, K. Miyata, R. Satou, L. L. Hamm, et al. Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive Patients Hypertension, February 1, 2009; 53(2): 344 - 350. [Abstract] [Full Text] [PDF]

				H. Kobori, A. Katsurada, K. Miyata, N. Ohashi, R. Satou, T. Saito, Y. Hagiwara, K. Miyashita, and L. G. Navar Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1257 - F1263. [Abstract] [Full Text] [PDF]

				H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF]

				A. Katsurada, Y. Hagiwara, K. Miyashita, R. Satou, K. Miyata, N. Ohashi, L. G. Navar, and H. Kobori Novel sandwich ELISA for human angiotensinogen Am J Physiol Renal Physiol, September 1, 2007; 293(3): F956 - F960. [Abstract] [Full Text] [PDF]

				H. Kobori, Y. Ozawa, R. Satou, A. Katsurada, K. Miyata, N. Ohashi, N. Hase, Y. Suzaki, C. D. Sigmund, and L. G. Navar Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice Am J Physiol Renal Physiol, September 1, 2007; 293(3): F938 - F945. [Abstract] [Full Text] [PDF]

				M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]

				L. A. Campos, R. Plehm, J. Cipolla-Neto, M. Bader, and O. C. Baltatu Altered circadian rhythm reentrainment to light phase shifts in rats with low levels of brain angiotensinogen Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1122 - R1127. [Abstract] [Full Text] [PDF]

				B. Maul, W. Krause, K. Pankow, M. Becker, F. Gembardt, N. Alenina, T. Walther, M. Bader, and W.-E. Siems Central angiotensin II controls alcohol consumption via its AT1 receptor FASEB J, September 1, 2005; 19(11): 1474 - 1481. [Abstract] [Full Text] [PDF]

				M. C. Zimmerman, E. Lazartigues, R. V. Sharma, and R. L. Davisson Hypertension Caused by Angiotensin II Infusion Involves Increased Superoxide Production in the Central Nervous System Circ. Res., July 23, 2004; 95(2): 210 - 216. [Abstract] [Full Text] [PDF]

				H. Wang, B. S. Huang, D. Ganten, and F. H.H. Leenen Prevention of Sympathetic and Cardiac Dysfunction After Myocardial Infarction in Transgenic Rats Deficient in Brain Angiotensinogen Circ. Res., April 2, 2004; 94(6): 843 - 849. [Abstract] [Full Text] [PDF]

				M. Bader and D. Ganten It's Renin in the Brain: Transgenic Animals Elucidate the Brain Renin-Angiotensin System Circ. Res., January 11, 2002; 90(1): 8 - 10. [Full Text] [PDF]

				O. Baltatu, M. A. P. Fontes, M. J. Campagnole-Santos, S. Caligiorni, D. Ganten, R. A. S. Santos, and M. Bader Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R428 - R433. [Abstract] [Full Text] [PDF]

				S. Kagiyama, A. Varela, M. I. Phillips, and S. M. Galli Antisense Inhibition of Brain Renin-Angiotensin System Decreased Blood Pressure in Chronic 2-Kidney, 1 Clip Hypertensive Rats Hypertension, February 1, 2001; 37(2): 371 - 375. [Abstract] [Full Text] [PDF]

				O. Baltatu, B. J. Janssen, G. Bricca, R. Plehm, J. Monti, D. Ganten, and M. Bader Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen Hypertension, February 1, 2001; 37(2): 408 - 413. [Abstract] [Full Text] [PDF]

				B. S. Huang, D. Ganten, and F. H. H. Leenen Responses to Central Na+ and Ouabain Are Attenuated in Transgenic Rats Deficient in Brain Angiotensinogen Hypertension, February 1, 2001; 37(2): 683 - 686. [Abstract] [Full Text] [PDF]

				J. Monti, M. Schinke, M. Bohm, D. Ganten, M. Bader, and G. Bricca Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN) Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R233 - R240. [Abstract] [Full Text] [PDF]